These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 4660079

  • 1. Intravenous infusion of prostaglandin F2alpha in the mid-luteal phase of the normal human menstrual cycle.
    Jewelewicz R, Cantor B, Dyrenfurth I, Warren MP, Vande Wiele RL.
    Prostaglandins; 1972 Jun; 1(6):443-51. PubMed ID: 4660079
    [No Abstract] [Full Text] [Related]

  • 2. The effect of vaginally administered prostaglandin F2alpha on corpus luteum function.
    Bolognese RJ, Corson SL.
    Am J Obstet Gynecol; 1973 Sep 15; 117(2):240-5. PubMed ID: 4728875
    [Abstract] [Full Text] [Related]

  • 3. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women.
    Arrata WS, Chatterton RT.
    Am J Obstet Gynecol; 1974 Dec 01; 120(7):954-9. PubMed ID: 4429112
    [Abstract] [Full Text] [Related]

  • 4. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R, Osman P, Dullaart J, de Greef WJ, Uilenbroek JT, de Jong FH.
    J Endocrinol; 1975 Jan 01; 64(1):37-47. PubMed ID: 1167896
    [Abstract] [Full Text] [Related]

  • 5. Transient decline in serum progesterone levels during prostaglandin F2alpha infusion in the midluteal phase of the normal human menstrual cycle.
    Coudert SP, Winter JS, Faiman C.
    Am J Obstet Gynecol; 1974 Jul 15; 119(6):755-61. PubMed ID: 4842261
    [No Abstract] [Full Text] [Related]

  • 6. The effect of prostaglandin F2 alpha infusion on corpus luteum function.
    Jones GS, Wentz AG.
    Am J Obstet Gynecol; 1972 Oct 01; 114(3):393-404. PubMed ID: 4637460
    [Abstract] [Full Text] [Related]

  • 7. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M, Rubin BL, Ossowski R.
    Am J Obstet Gynecol; 1972 Mar 01; 112(5):629-39. PubMed ID: 5059593
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 and the luteal phase of the menstrual cycle: effects on blood progesterone, estradiol, cortisol, and growth hormone levels.
    Henzl MR, Ortega E, Cortés-Gallegos V, Tomlinson RV, Segre EJ.
    J Clin Endocrinol Metab; 1973 Apr 01; 36(4):784-7. PubMed ID: 4686386
    [Abstract] [Full Text] [Related]

  • 9. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
    Roseff SJ, Kettel LM, Rivier J, Burger HG, Baulieu E, Yen SS.
    Fertil Steril; 1990 Nov 01; 54(5):805-10. PubMed ID: 2226914
    [Abstract] [Full Text] [Related]

  • 10. Perturbations of the human menstrual cycle by oxymetholone.
    Cox DW, Heinrichs WL, Paulsen AC, Conrad SH, Schiller HS, Hezl MR, Herrmann WL.
    Am J Obstet Gynecol; 1975 Jan 01; 121(1):121-6. PubMed ID: 1115110
    [Abstract] [Full Text] [Related]

  • 11. Transient luteolytic effect of prostaglandin F2alpha in the human.
    Wentz AC, Jones GS.
    Obstet Gynecol; 1973 Aug 01; 42(2):172-81. PubMed ID: 4721404
    [No Abstract] [Full Text] [Related]

  • 12. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG, Liu J, Ulmann A, Baulieu E, Yen SS.
    J Clin Endocrinol Metab; 1988 Mar 01; 66(3):508-17. PubMed ID: 2832438
    [Abstract] [Full Text] [Related]

  • 13. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS, Harlin J, Zaidi AA, Diczfalusy E.
    Fertil Steril; 1980 May 01; 33(5):493-500. PubMed ID: 6768597
    [Abstract] [Full Text] [Related]

  • 14. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM, Marcus SL, Saxena BB, Beling CG, Connell EB.
    Fertil Steril; 1971 May 01; 22(5):332-44. PubMed ID: 4102481
    [Abstract] [Full Text] [Related]

  • 15. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L, Caldwell BV, Brock WA, Anderson GG, Hobbins JC.
    J Clin Endocrinol Metab; 1972 Mar 01; 34(3):531-6. PubMed ID: 5011257
    [Abstract] [Full Text] [Related]

  • 16. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB, Salvatierra AM, Romero C, Spitz IM.
    J Clin Endocrinol Metab; 1987 Dec 01; 65(6):1272-7. PubMed ID: 3119656
    [Abstract] [Full Text] [Related]

  • 17. [Blockade of LH and FSH peaks by low doses of exogenous progesterone in the human female (author's transl)].
    Netter A, Gorins A, Thomas K, Cohen M, Joubinaux J.
    Ann Endocrinol (Paris); 1973 Dec 01; 34(4):430-5. PubMed ID: 4779738
    [Abstract] [Full Text] [Related]

  • 18. The sequence of pituitary responses to synthetic luteinizing hormone releasing hormone (LH-RH) throughout the normal menstrual cycle.
    Grimes EM, Thompson IE, Taymor ML.
    Acta Endocrinol (Copenh); 1975 Aug 01; 79(4):625-34. PubMed ID: 1098349
    [Abstract] [Full Text] [Related]

  • 19. Investigation of Danazol as a contraceptive agent.
    Wentz AC, Jones GS, Sapp KC.
    Contraception; 1976 May 01; 13(5):619-30. PubMed ID: 1261264
    [Abstract] [Full Text] [Related]

  • 20. Prostaglandin F 2alpha: its effect on the corpus luteum of the menstrual cycle.
    LeMaire WJ, Shapiro AG.
    Prostaglandins; 1972 Apr 01; 1(4):259-67. PubMed ID: 4660073
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.